Table 1.
Clinical information and characteristics of MTLE patients and controls.
| RMTLE | LMTLE | Controls | |
|---|---|---|---|
| N (female) | 11 (6) | 11 (8) | 19 (10) |
| age (m ± std, years) | 49 ± 12 | 42 ± 9 | 42 ± 13 |
| Right-Handers (N) | 10 | 10 | 16 |
| Duration of Epilepsy (m ± std, yrs.) | 27 ± 16 | 25 ± 15 | - |
| Seizure Type | CPS: 8 | CPS: 6 | - |
| CPS*: 1 | CPS*: 2 | - | |
| CPS**: 0 | CPS**: 2 | - | |
| CPS/SPS: 1 | CPS/SPS: 1 | - | |
| SPS: 1 | SPS: 0 | - | |
| Full Scale IQ (m ± std) | 94 ± 14 | 94 ± 15 | - |
| Anti-Depressive Medication % (N) | Lexapro: 18% (2) | Lexapro: 9% (1) | Lexapro: 0 |
| Zyprexa: 9% (1)¥ | Zyprexa: 0 | Zyprexa: 0 | |
| Ativan: 9% (1)¥ | Ativan: 0 | Ativan: 0 | |
| Zoloft: 9% (1) | Zoloft: 0 | Zoloft: 0 | |
| Celexa: 9% (1) | Celexa: 9% (1) | Celexa: 0 | |
| Depressive and Anxiety level (m ± std) | |||
| PAI-ARD | 52 ± 12 | 52 ± 11μ | 50 ± 10π |
| PAI-ANX | 56 ± 8 | 55 ± 13μ | 50 ± 10π |
| PAI-DEP | 55 ± 13 | 55 ± 12μ | 50 ± 10π |
¥: Same patient; π: Normative results obtained on 1000 healthy participants (Morey, 1991); μ : Average done on 9 LMTLE patients; μ : Average done on 9 LMTLE patients
*
CPS as primary type with rare secondary generalized seizures
**
CPS as primary type with rare generalized tonic-clonic seizures.
Abbreviations: PAI: Personality Assessment Inventory, ANX: Anxiety subscale, ARD: Anxiety-Related Disorders subscale, DEP: Depression subscale; CPS: Complex Partial Seizures; SPS: Secondary Partial Seizures.